IL10 and chronic obstructive pulmonary disease: On this basis, we hypothesized that, in LC patients with COPD, the immune profile characterized by the expression of Treg cells, NK cells, plasmatic cells, and levels of the cytokines’ interferon-gamma and IL-10 within the tumors may differ from LC patients with no underlying COPD.